In the March 2017 issue of La Tribune de l’Assurance Thomas ROCHE explains the various controversies that will result from the Jardé law Thomas ROCHE, a partner in the "Life Sciences" department, outlines the three major changes brought about by the application of the Jardé law, particularly in relation to risk-inherent interventional research...Read
Practice areasLife sciences
Thomas ROCHE is co-head of the Life Sciences Department.
He assists health and medical technology companies at all stages of their product lifecycles, including development, preclinical or clinical evaluation, marketing, reimbursement and distribution.
His interests lie more specifically in clinical research and its promotion, issues relating to health data (he works as an external DPO), as well as various contracts regulating the development of these activities.
Understanding of the regulatory challenges facing health companies enables him to provide regular support in the framework of audits or administrative inspections that are likely to lead to health measures.
He is fluent in legal English.
Thomas ROCHE graduated from Jean Moulin Lyon III University. He has a DESS postgraduate qualification in Business Law and Taxation as well as a DJCE postgraduate qualification in Business Law. He gained professional accreditation in 1999.
In 2000, he began his career with an initial six-month experience in MONTREAL before joining the law firm FÉRY & Associés in LYON as an associate lawyer.
In late 2002, he founded the law firm ROCHE Avocats, specializing in innovative technologies (life science and information and communication technologies), which he developed until 2013 to join DELSOL Avocats and create the Life Sciences Department.
Thomas ROCHE wrote an article for the April 2016 Expertises des Systèmes d’Information analysing an important change in the law relating to data protection Thomas ROCHE, a partner in the "Life Sciences" department, takes a stand in an article published in the April 2016 issue of Expertises des Systèmes d’Information about the recent merger of...Read